Optimal Asset Management’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$2.65M Buy
6,235
+7
+0.1% +$2.95K 0.33% 105
2021
Q2
$2.24M Hold
6,228
0.26% 139
2021
Q1
$1.75M Buy
6,228
+3,409
+121% +$976K 0.23% 157
2020
Q4
$799K Sell
2,819
-2,821
-50% -$792K 0.11% 277
2020
Q3
$1.55M Buy
5,640
+4,122
+272% +$1.09M 0.22% 145
2020
Q2
$345K Buy
+1,518
New +$298K 0.06% 365

Other funds holding WST

Optimal Asset Management's WST Position: Q3 2021 in Review

Optimal Asset Management increased its West Pharmaceutical (WST) stake by 0.11% in Q3 2021, buying an estimated $2.95K and bringing the position to 6,235 shares worth $2.65M. The position accounts for 0.33% of the portfolio, ranked #105.

Optimal Asset Management first reported a position in WST in Q2 2020 and has held it in 6 quarters since. 669 funds tracked by Wall St. Rank hold WST as of Q3 2021.

  • Optimal Asset Management held 6,235 shares of West Pharmaceutical worth $2.65M as of Q3 2021.
  • Optimal Asset Management bought 7 West Pharmaceutical shares in Q3 2021, an estimated $2.95K.
  • West Pharmaceutical made up 0.33% of Optimal Asset Management's portfolio in Q3 2021, its #105 holding.
  • Optimal Asset Management first reported a position in West Pharmaceutical in Q2 2020 and has held it in 6 quarters since.
  • 669 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2021.

Based on Optimal Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.